CGEN logo

Compugen (CGEN) Company Overview

Profile

Full Name:

Compugen Ltd.

Sector:

Healthcare

Industry:

Biotechnology

Country:

Israel

IPO:

August 11, 2000

Indexes:

Not included

Description:

Compugen Ltd. is an Israeli company specializing in therapeutic discoveries and developments. It was registered in Israel in 1993. The company's main focus is on discovering new drugs and developing therapeutic agents in the field of cancer immunotherapy. The innovative immuno-oncology program consists of three clinical-stage programs targeting immune checkpoints: COM701, BAY 1905254, and COM902. COM701 is a first-in-class antibody for the treatment of solid tumors, being clinically developed in collaboration with BMS (Bristol-Myers Squibb). BAY 1905254 has demonstrated anti-tumor activity as a monotherapy, and it also has additional anti-tumor activity in combination with other cancer therapy approaches, indicating the possibility of multiple combined uses in cancer immunotherapy. COM902 is a therapeutic antibody being developed for patients with advanced malignant neoplasms.

Key Details

Price

$1.98

Annual Revenue

$33.46 M(+346.12% YoY)

Annual EPS

-$0.21(+46.15% YoY)

Annual ROE

-26.19%

Beta

1.78

Events Calendar

Earnings

Next earnings date:

Mar 4, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 5, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

May 21, 24 Truist Securities
Buy
Mar 8, 24 Truist Securities
Buy
Dec 19, 23 Stifel
Buy
Aug 23, 23 Truist Securities
Buy
Aug 7, 23 EF Hutton
Buy
Jun 6, 23 EF Hutton
Buy
May 26, 23 EF Hutton
Buy
May 24, 23 EF Hutton
Buy
May 16, 23 Oppenheimer
Outperform
Feb 28, 23 Oppenheimer
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Compugen?
  • Does Compugen pay dividends?
  • What sector is Compugen in?
  • What industry is Compugen in?
  • What country is Compugen based in?
  • When did Compugen go public?
  • Is Compugen in the S&P 500?
  • Is Compugen in the NASDAQ 100?
  • Is Compugen in the Dow Jones?
  • When was Compugen's last earnings report?
  • When does Compugen report earnings?
  • Should I buy Compugen stock now?

What is the ticker symbol for Compugen?

The ticker symbol for Compugen is NASDAQ:CGEN

Does Compugen pay dividends?

No, Compugen does not pay dividends

What sector is Compugen in?

Compugen is in the Healthcare sector

What industry is Compugen in?

Compugen is in the Biotechnology industry

What country is Compugen based in?

Compugen is headquartered in Israel

When did Compugen go public?

Compugen's initial public offering (IPO) was on August 11, 2000

Is Compugen in the S&P 500?

No, Compugen is not included in the S&P 500 index

Is Compugen in the NASDAQ 100?

No, Compugen is not included in the NASDAQ 100 index

Is Compugen in the Dow Jones?

No, Compugen is not included in the Dow Jones index

When was Compugen's last earnings report?

Compugen's most recent earnings report was on Nov 12, 2024

When does Compugen report earnings?

The next expected earnings date for Compugen is Mar 4, 2025

Should I buy Compugen stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions